{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T11:56:40Z","timestamp":1774612600273,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T00:00:00Z","timestamp":1650931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T00:00:00Z","timestamp":1650931200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004845","name":"Haramaya University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004845","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Group A\n                      <jats:italic>Streptococcus<\/jats:italic>\n                      has been recognized as an important human pathogen and it remains among the top ten causes of mortality from an infectious disease. Group A\n                      <jats:italic>Streptococcus<\/jats:italic>\n                      throat carriage plays an important role in the development of infection and transmission to contacts. In Ethiopia, there is little information about screening of children for group A\n                      <jats:italic>Streptococcus<\/jats:italic>\n                      carriage.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      This study was aimed to assess the magnitude of throat carriage, associated factors, and antimicrobial susceptibility pattern of group A\n                      <jats:italic>Streptococcus<\/jats:italic>\n                      among healthy school children in Jigjiga city, Eastern Ethiopia from 12 April to 27 May 2021.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>\n                      A cross-sectional study was conducted enrolled by simple random sampling. Data on socio-demographic and related characteristics were gathered using pretested structured questionnaire. The throat sample was collected from 462 healthy school children and immediately transported to Jigjiga University Sultan Sheik Hassan referral hospital laboratory for investigation. Identification of group A\n                      <jats:italic>Streptococcus<\/jats:italic>\n                      was done by colony characterstics, gram staining, catalase negativity, bacitracin sensitivity, and Pyrrolidonyl arylamidase tests. Antibiotic susceptibility test was done on Muller-Hinton agar containing 5% sheep blood by modified Kirby-Bauer disc diffusion method. The data were coded, cleaned, and entered onto EpiData Version 3.1 then exported to SPSS version 26.0 for analysis. Bivariate and multivariable logistic regression through adjusted odds ratio (AOR) was used to determine the relationship between culture-positivity rates of GAS and predictor variables. A\n                      <jats:italic>p<\/jats:italic>\n                      -value\u2009&lt;\u20090.05 was taken as statistically significant on multivariable analysis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The overall prevalence of group A\n                      <jats:italic>Streptococcus<\/jats:italic>\n                      throat culture rate was 10.6% (95%CI; 8.1%\u201413.7%). Previous family member who had a sore throat, children living with larger families (more than 11 members), and children living with non-immediate families were significantly associated with culture-positivity rates of GAS. Children who live with a family member with a sore throat compared with those who lived with in a family with no history of sore throat (AOR\u2009=\u20092.51; 95%CI 1.09\u20135.73), children who live with a large family comared to children living in families with less members (AOR\u2009=\u20094.64; 95% CI 1.53\u201314.1), and children who live with non-immediate families compared to children living with their mothers (AOR\u2009=\u20093.65; 95% CI 1.39 \u2013 9.61), showed significant association with group A\n                      <jats:italic>Streptococcus<\/jats:italic>\n                      carriage rate. Resistance to all other antibiotics tested was low (&lt;\u20095%). Multidrug resistance was found in 4.1% of isolates.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      The present study showed 10.6% throat carriage of group A\n                      <jats:italic>Streptococcus<\/jats:italic>\n                      . Family member with a sore throat, having a large family, and living with non-immediate families have all been identified as independent predictors of carriage prevalence.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12887-022-03294-2","type":"journal-article","created":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T01:15:01Z","timestamp":1650935701000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Throat carriage rate, associated factors, and antimicrobial susceptibility pattern of group A Streptococcus among healthy school children in Jigjiga City, Eastern Ethiopia"],"prefix":"10.1186","volume":"22","author":[{"given":"Shamil","family":"Barsenga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Habtamu","family":"Mitiku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tewodros","family":"Tesfa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadesse","family":"Shume","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,26]]},"reference":[{"key":"3294_CR1","first-page":"1","volume":"368","author":"A Ralph","year":"2012","unstructured":"Ralph A, Carapetis J. Group A streptococcal diseases and their global burden. Curr Top Microbiol Immunol. 2012;368:1\u201327.","journal-title":"Curr Top Microbiol Immunol"},{"key":"3294_CR2","unstructured":"World Health Organization. The current evidence for the burden of group A streptococcal diseases. World Health Organization; 2005."},{"key":"3294_CR3","volume-title":"Streptococcus pyogenes: Basic Biology to Clinical Manifestations","author":"A Efstratiou","year":"2016","unstructured":"Efstratiou A, Lamagni T. Epidemiology of Streptococcus pyogenes. In: Ferretti JJ, Stevens DL, Fischetti VA, editors. Streptococcus pyogenes: Basic Biology to Clinical Manifestations. Oklahoma City: University of Oklahoma Health Sciences Center \u00a9 The University of Oklahoma Health Sciences Center; 2016."},{"key":"3294_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/82_2012_280","volume-title":"Host-pathogen interactions in streptococcal diseases","author":"AP Ralph","year":"2012","unstructured":"Ralph AP, Carapetis JR, Group a streptococcal diseases and their global burden. Host-pathogen interactions in streptococcal diseases. 2012. 1\u201327."},{"key":"3294_CR5","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.ijcard.2019.11.109","volume":"307","author":"DD Barth","year":"2020","unstructured":"Barth DD, Moloi A, Mayosi BM, Engel ME. Prevalence of group A Streptococcal infection in Africa to inform GAS vaccines for rheumatic heart disease: a systematic review and meta-analysis. Int J Cardiol. 2020;307:200\u20138.","journal-title":"Int J Cardiol"},{"issue":"2","key":"3294_CR6","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1086\/340949","volume":"35","author":"A Bisno","year":"2002","unstructured":"Bisno A, Gerber M, Gwaltney J, Kaplan E, Schwartz R, Infectious Diseases Society of America. Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Clin Infect Dis. 2002;35(2):113\u201325.","journal-title":"Clin Infect Dis"},{"key":"3294_CR7","first-page":"57","volume-title":"Rosen\u2019s emergency medicine: Concepts and clinical practice","author":"M Platt","year":"2010","unstructured":"Platt M, Vicario S, Marx J. Rosen\u2019s emergency medicine: Concepts and clinical practice. 7th ed. Philadelphia: Mosby Elsevier; 2010. p. 57.","edition":"7"},{"issue":"2","key":"3294_CR8","first-page":"434","volume":"10","author":"ME Engel","year":"2013","unstructured":"Engel ME, Mayosi BM. Clinical and epidemiological aspects of streptococcus pyogenes pharyngitis and carriage in Africa: streptococcus pyogenes in Africa. SA Heart. 2013;10(2):434\u20139.","journal-title":"SA Heart"},{"key":"3294_CR9","first-page":"g299","volume":"348","author":"J Matthys","year":"2014","unstructured":"Matthys J. There are still problems in identifying who will develop complications of sore throat in primary care. BMJ (Clin Res Ed). 2014;348:g299.","journal-title":"BMJ (Clin Res Ed)"},{"issue":"72","key":"3294_CR10","first-page":"329","volume":"13","author":"A Henningham","year":"2012","unstructured":"Henningham A, Barnett TC, Maamary PG, Walker MJ. Pathogenesis of group A streptococcal infections. Discov Med. 2012;13(72):329\u201342.","journal-title":"Discov Med"},{"issue":"4","key":"3294_CR11","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.meegid.2009.03.002","volume":"9","author":"DE Bessen","year":"2009","unstructured":"Bessen DE. Population biology of the human restricted pathogen, streptococcus pyogenes. Infect Genet Evol. 2009;9(4):581\u201393.","journal-title":"Infect Genet Evol"},{"key":"3294_CR12","unstructured":"Sanyahumbi AS, Colquhoun S, Wyber R, Carapetis JR. Global disease burden of group A Streptococcus. Streptococcus pyogenes: basic biology to clinical manifestations. University of Oklahoma Health Sciences Center; 2016."},{"issue":"3","key":"3294_CR13","doi-asserted-by":"publisher","first-page":"e0006335","DOI":"10.1371\/journal.pntd.0006335","volume":"12","author":"J Oliver","year":"2018","unstructured":"Oliver J, MalliyaWadu E, Pierse N, Moreland NJ, Williamson DA, Baker MG. Group A Streptococcus pharyngitis and pharyngeal carriage: a meta-analysis. PLoS Negl Trop Dis. 2018;12(3):e0006335.","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"3294_CR14","first-page":"125","volume":"49","author":"A Abdissa","year":"2011","unstructured":"Abdissa A, Asrat D, Kronvall G, Shitu B, Achiko D, Zeidan M, et al. Throat carriage rate and antimicrobial susceptibility pattern of group A Streptococci (GAS) in healthy Ethiopian school children. Ethiop Med J. 2011;49(2):125\u201330.","journal-title":"Ethiop Med J"},{"issue":"1","key":"3294_CR15","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1186\/s13104-019-4601-9","volume":"12","author":"A Anja","year":"2019","unstructured":"Anja A, Beyene G, Daka D. Asymptomatic pharyngeal carriage rate of Streptococcus pyogenes, its associated factors and antibiotic susceptibility pattern among school children in Hawassa town, southern Ethiopia. BMC Res Notes. 2019;12(1):564.","journal-title":"BMC Res Notes"},{"key":"3294_CR16","volume-title":"General school information","author":"Jigjiga City Administration Education Bureau","year":"2020","unstructured":"Jigjiga City Administration Education Bureau. General school information. Jigjiga: Jigjiga City Administration Education Bureau; 2020."},{"issue":"1","key":"3294_CR17","doi-asserted-by":"publisher","first-page":"18","DOI":"10.18320\/JIMD\/201704.0118","volume":"4","author":"A Mukundan","year":"2017","unstructured":"Mukundan A, Vijayakumar S. Pharyngeal carriage of Group A streptococci among school children. J Int Med Dent. 2017;4(1):18\u201326.","journal-title":"J Int Med Dent"},{"key":"3294_CR18","unstructured":"Brooks GF, Butel JS, Morse SA. Jawetz, Melnick, & Adelberg's medical microbiology: Lange Medical Books\/McGraw-Hill. Medical Pub. Division; 2004."},{"key":"3294_CR19","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9780511543470","volume-title":"District laboratory practice in tropical countries, part 2: Cambridge university press","author":"M Cheesbrough","year":"2006","unstructured":"Cheesbrough M. District laboratory practice in tropical countries, part 2: Cambridge university press. 2006."},{"key":"3294_CR20","volume-title":"Performance Standards for Antimicrobial Susceptibility Testing","author":"Clinical and Laboratory Standards Institute","year":"2020","unstructured":"Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. Wayne: CLSI supplement; 2020."},{"key":"3294_CR21","volume-title":"The Prevalence of Streptococcus Pyogenes and its emm Gene Types among School Children in AI Ain, UAE","author":"FH Ali Al Shamisi","year":"2016","unstructured":"Ali Al Shamisi FH. The Prevalence of Streptococcus Pyogenes and its emm Gene Types among School Children in AI Ain, UAE. 2016."},{"key":"3294_CR22","first-page":"169","volume":"14","author":"A Prajapati","year":"2012","unstructured":"Prajapati A, Rai S, Mukhiya R, Karki A. Study on carrier rate of Streptococcus pyogenes among the school children and antimicrobial susceptibility pattern of isolates. Nepal Med Coll J. 2012;14:169\u201371.","journal-title":"Nepal Med Coll J"},{"issue":"1","key":"3294_CR23","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1186\/s13104-019-4370-5","volume":"12","author":"AM Othman","year":"2019","unstructured":"Othman AM, Assayaghi RM, Al-Shami HZ, Saif-Ali R. Asymptomatic carriage of Streptococcus pyogenes among school children in Sana\u2019a city, Yemen. BMC Res Notes. 2019;12(1):339.","journal-title":"BMC Res Notes"},{"issue":"1","key":"3294_CR24","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1186\/s12879-017-2353-5","volume":"17","author":"I Nayiga","year":"2017","unstructured":"Nayiga I, Okello E, Lwabi P, Ndeezi G. Prevalence of group a streptococcus pharyngeal carriage and clinical manifestations in school children aged 5\u201315 yrs in Wakiso District, Uganda. BMC Infect Dis. 2017;17(1):248.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"3294_CR25","doi-asserted-by":"publisher","first-page":"377","DOI":"10.5144\/0256-4947.2015.377","volume":"35","author":"SM Abd El-Ghany","year":"2015","unstructured":"Abd El-Ghany SM, Abdelmaksoud AA, Saber SM, Abd El Hamid DH. Group A beta-hemolytic streptococcal pharyngitis and carriage rate among Egyptian children: a case-control study. Ann Saudi Med. 2015;35(5):377\u201382.","journal-title":"Ann Saudi Med"},{"issue":"2","key":"3294_CR26","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3961\/jpmph.15.073","volume":"50","author":"G Delpech","year":"2017","unstructured":"Delpech G, Sparo M, Baldaccini B, Pourcel G, Lissarrague S, Allende LG. Throat carriage rate and antimicrobial resistance of Streptococcus pyogenes in rural children in Argentina. J Prev Med Public Health. 2017;50(2):127.","journal-title":"J Prev Med Public Health"},{"issue":"2","key":"3294_CR27","first-page":"177","volume":"43","author":"S B\u00e9lard","year":"2015","unstructured":"B\u00e9lard S, Toepfner N, Arnold B, Alabi AS, Berner R. \u03b2-hemolytic streptococcal throat carriage and tonsillopharyngitis: a cross-sectional prevalence study in Gabon. Central Africa Infection. 2015;43(2):177\u201383.","journal-title":"Central Africa Infection"},{"issue":"1","key":"3294_CR28","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3126\/jnps.v33i1.7004","volume":"33","author":"A Manandhar","year":"2013","unstructured":"Manandhar A, Shah Y, Shrestha J. Study on the prevalence of beta haemolytic Streptococcus among school children. J Nepal Paediatric Soc. 2013;33(1):45\u20137.","journal-title":"J Nepal Paediatric Soc"},{"issue":"5","key":"3294_CR29","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1542\/peds.2006-3368","volume":"120","author":"MH Danchin","year":"2007","unstructured":"Danchin MH, Rogers S, Kelpie L, Selvaraj G, Curtis N, Carlin JB, et al. Burden of acute sore throat and group A streptococcal pharyngitis in school-aged children and their families in Australia. Pediatrics. 2007;120(5):950\u20137.","journal-title":"Pediatrics"},{"issue":"1","key":"3294_CR30","first-page":"63","volume":"51","author":"MMS Saleh","year":"2010","unstructured":"Saleh MMS. Carriage state of ga\u03b2hs among yemeni schoolchildren and the upper limit of normal for aso in different population groups. Iraqi J Sci. 2010;51(1):63\u201370.","journal-title":"Iraqi J Sci"},{"issue":"3","key":"3294_CR31","first-page":"87","volume":"21","author":"Q Faruq","year":"1995","unstructured":"Faruq Q, Rashid A, Ahmed J, Waiz A, Haque K, Rouf M, et al. Prevalence of streptococcal sorethroat in the school children of Dhaka. Bangladesh Med Res Counc Bull. 1995;21(3):87\u201394.","journal-title":"Bangladesh Med Res Counc Bull"},{"issue":"1","key":"3294_CR32","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1186\/s12879-016-1841-3","volume":"16","author":"N Zegeye","year":"2016","unstructured":"Zegeye N, Asrat D, Woldeamanuel Y, Habte A, Gedlu E, T\u00f8njum T, et al. Throat culture positivity rate and antibiotic susceptibility pattern of beta-hemolytic streptococci in children on secondary prophylaxis for rheumatic heart disease. BMC Infect Dis. 2016;16(1):510.","journal-title":"BMC Infect Dis"},{"key":"3294_CR33","doi-asserted-by":"publisher","first-page":"MBI. S12996","DOI":"10.4137\/MBI.S12996","volume":"6","author":"M Camara","year":"2013","unstructured":"Camara M, Dieng A, Boye CSB. Antibiotic susceptibility of streptococcus pyogenes isolated from respiratory tract infections in dakar, senegal. Microbiol Insights. 2013;6:MBI. S12996.","journal-title":"Microbiol Insights"},{"issue":"1","key":"3294_CR34","doi-asserted-by":"publisher","first-page":"73","DOI":"10.2478\/cejcr-2019-0011","volume":"2","author":"AA Bobia","year":"2019","unstructured":"Bobia AA, Blaj OA, Oancea D, Iulia-Cristina B, Radu-Vasile B, Delia-Ioana H, et al. The prevalence of beta hemolytic streptococcus in a children\u2019s tertiary care hospital in Timisoara. Cent Eur J Clin Res. 2019;2(1):73\u20138.","journal-title":"Cent Eur J Clin Res"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-022-03294-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-022-03294-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-022-03294-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T01:17:09Z","timestamp":1650935829000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-022-03294-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,26]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["3294"],"URL":"https:\/\/doi.org\/10.1186\/s12887-022-03294-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1256251\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-1256251\/v2","asserted-by":"object"}]},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,26]]},"assertion":[{"value":"25 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was conducted out after receiving ethical approval from Haramaya University College of Health Science and Medical Sciences Institutional Health Research Ethics Review Committee (IHRERC). This study was conducted in accordance with the Declaration of Helsinki. Each child's parent\/guardian has been sufficiently informed of the study's purpose and the importance of their participation by the data collectors and\/or the investigator. Written, Informed, voluntary, and signed consent were taken from all parents\/guardians and assent were taken from the child before commencing the study. All parents\/guardians were consulted about the benefit of the treatment by a pediatrician who works at Jigjiga University Sultan Shiek Hassen Referral Hospital and the drugs were given free of charge.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"There were no conflicts of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interests"}}],"article-number":"227"}}